Effect of Exclusive Enteral Nutrition on the Disease Process, Nutrition Status, and Gastrointestinal Microbiota for Chinese Children With Crohn's Disease
Wenjuan Tang,Ying Huang,Peng Shi,Yuhuan Wang,Ye Zhang,Aijuna Xue,Zifei Tang,Wenhui Hu,Hua Sun,Ping Zhang,Cuifang Zheng,Jieru Shi,Shengnan Wang,Xiaoxia Qiu,Xiaolan Lu,Shijian Miao,Yingying Meng
DOI: https://doi.org/10.1002/jpen.1938
2021-01-01
Journal of Parenteral and Enteral Nutrition
Abstract:Background The aim of this study was to prospectively study the effect of exclusive enteral nutrition (EEN) treatment on Chinese pediatric Crohn's disease (CD) patients. Methods Thirty-one newly diagnosed CD patients were enrolled in this study and treated with EEN for 8 weeks. Twelve healthy controls (HCs) donated their fecal samples. Statistical methods were used to compare the differences. Results According to the Simple Endoscopic Score for CD (SES-CD) at the end of the EEN treatment, 21 patients with SES-CD <= 4 were classified into the remission group (CD-RE), and 10 patients with SES-CD >4 were classified into the nonremission group (CD-NRE). After EEN therapy, there was a significant decrease in the SES-CD, the weighted Pediatric Crohn's Disease Activity Index (wPCDAI), and fecal calprotectin (FCP) in the CD-RE group (allP< .001). The wPCDAI and FCP also decreased in the CD-NRE group (bothP< .05). In terms of nutrition improvement, the CD-RE group patients showed more improvement in weight gain, hemoglobin, and serum albumin level than the CD-NRE group patients (allP< .05). For the microbiota, the CD patients had a lower bacterial diversity and different bacterial community compared with HCs. EEN increased overall diversity and was able to shift the dysbiosis in CD patients toward a healthier state. Absence of improvement in wPCDAI and Shannon index at 2 weeks predicts poor response at the end of EEN. Conclusion EEN can be used in most Chinese pediatric CD patients to induce remission and improve nutrition.